Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Other financing activities (2018 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Other financing activities for 6 consecutive years, with $15000.0 as the latest value for Q2 2025.

  • Quarterly Other financing activities fell 91.62% to $15000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $52000.0 through Sep 2025, down 92.67% year-over-year, with the annual reading at $651000.0 for FY2024, 172.38% up from the prior year.
  • Other financing activities for Q2 2025 was $15000.0 at Xtant Medical Holdings, down from $34000.0 in the prior quarter.
  • The five-year high for Other financing activities was $436000.0 in Q1 2024, with the low at $3000.0 in Q4 2024.
  • Average Other financing activities over 4 years is $100555.6, with a median of $40000.0 recorded in 2023.
  • The sharpest move saw Other financing activities soared 990.0% in 2024, then crashed 92.2% in 2025.
  • Over 4 years, Other financing activities stood at $104000.0 in 2021, then crashed by 41.35% to $61000.0 in 2023, then plummeted by 95.08% to $3000.0 in 2024, then skyrocketed by 400.0% to $15000.0 in 2025.
  • According to Business Quant data, Other financing activities over the past three periods came in at $15000.0, $34000.0, and $3000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.